Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17826670 | 1.00 | DGAT1 (0.42) | DGAT1ALDH1A1TSHRSRCMAPT | |
| SCHEMBL11275466 | 0.90 | DGAT1 (0.39) | DGAT1ALDH1A1TSHRSRCMAPT | |
| SCHEMBL9692472 | 0.79 | ALDH1A1 (0.40) | DGAT1ALDH1A1SRCMAPTKCNN4 | |
| SCHEMBL4070809 | 0.78 | ALDH1A1 (0.45) | DGAT1ALDH1A1TSHRSRCMAPT | |
| SCHEMBL22433018 | 0.76 | DGAT1 (0.41) | DGAT1ALDH1A1TSHRSRCKCNN4 | |
| SCHEMBL16599779 | 0.75 | — | — | |
| SCHEMBL1661824 | 0.74 | DGAT1 (0.44) | DGAT1ALDH1A1TSHRSRCMAPT | |
| SCHEMBL1022153 | 0.74 | DGAT1 (0.56) | DGAT1ALDH1A1TSHRSRCMAPT | |
| SCHEMBL12083395 | 0.74 | ALDH1A1 (0.42) | DGAT1ALDH1A1TSHRSRCMAPT | |
| SCHEMBL13646326 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2553145-B1 | ETCH RESISTANT ALUMINA BASED COATINGS | PIBOND OY (FI) | 2022-09-21 | — | — | EP | disclosed |
| EP-2764052-B1 | IRON(III) CONTAINING COMPLEX AND CONDENSATION REACTION CATALYSTS, METHODS FOR PREPARING THE CATALYSTS, AND COMPOSITIONS CONTAINING THE CATALYSTS | DOW SILICONES CORP (US) | 2018-07-18 | — | — | EP | disclosed |
| US-20170200615-A1 | ETCH RESISTANT ALUMINA BASED COATINGS | PIBOND (ZHEJIANG) NEW MATERIALS CO., LTD (CN) | 2017-07-13 | — | — | US | disclosed |
| US-9564339-B2 | Etch resistant alumina based coatings | PIBOND OY (FI) | 2017-02-07 | — | — | US | disclosed |
| US-9328205-B2 | Iron(III) containing complex and condensation reaction catalysts, methods for preparing the catalysts, and compositions containing the catalysts | DOW CORNING CORPORATION (US) | 2016-05-03 | — | — | US | disclosed |
| US-9328205-B2 | Iron(III) containing complex and condensation reaction catalysts, methods for preparing the catalysts, and compositions containing the catalysts | DOW CORNING CORPORATION (US) | 2016-05-03 | — | — | US | disclosed |
| US-9328205-B2 | Iron(III) containing complex and condensation reaction catalysts, methods for preparing the catalysts, and compositions containing the catalysts | DOW CORNING CORPORATION (US) | 2016-05-03 | — | — | US | disclosed |
| EP-2903586-A2 | COMPOSITION | Trigiante, Giuseppe (GB) | 2015-08-12 | — | — | EP | disclosed |
| US-20140371056-A1 | Iron(III) Containing Complex and Condensation Reaction Catalysts, Methods for Preparing the Catalysts, and Compositions Containing the Catalysts | DOW COMING CORPORATION (US) | 2014-12-18 | — | — | US | disclosed |
| US-20140371056-A1 | Iron(III) Containing Complex and Condensation Reaction Catalysts, Methods for Preparing the Catalysts, and Compositions Containing the Catalysts | DOW COMING CORPORATION (US) | 2014-12-18 | — | — | US | disclosed |
| US-7939685-B2 | Hydroxylation of β-dicarbonyls with zirconium catalysts | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-05-10 | — | — | US | disclosed |
| US-7939685-B2 | Hydroxylation of β-dicarbonyls with zirconium catalysts | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-05-10 | — | — | US | disclosed |
| US-20100185014-A1 | Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts | FMC CORPORATION | 2010-07-22 | — | — | US | disclosed |
| US-20100185014-A1 | Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts | FMC CORPORATION | 2010-07-22 | — | — | US | disclosed |
| US-7718818-B2 | Hydroxylation of beta-dicarbonyls with zirconium catalysts | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-05-18 | — | — | US | disclosed |
| US-7718818-B2 | Hydroxylation of beta-dicarbonyls with zirconium catalysts | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-05-18 | — | — | US | disclosed |
| US-20080306259-A1 | HYDROXYLATION OF BETA-DICARBONYLS WITH ZIRCONIUM CATALYSTS | FMC CORPORATION | 2008-12-11 | — | — | US | disclosed |
| US-20080306259-A1 | HYDROXYLATION OF BETA-DICARBONYLS WITH ZIRCONIUM CATALYSTS | FMC CORPORATION | 2008-12-11 | — | — | US | disclosed |
| US-7414157-B2 | Hydroxylation of β-dicarbonyls with zirconium catalysts | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-08-19 | — | — | US | disclosed |
| US-7414157-B2 | Hydroxylation of β-dicarbonyls with zirconium catalysts | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100185014-A1 | Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts | CBR3, CBR1, NOXO1 | DGAT1 1727/4885ALDH1A1 258/4885TSHR 3292/4885 |
| US-20080306259-A1 | HYDROXYLATION OF BETA-DICARBONYLS WITH ZIRCONIUM CATALYSTS | CBR3, CBR1, ASPH | DGAT1 2218/4885ALDH1A1 260/4885TSHR 3942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.